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ABSTRACT
Pomegranate (Punica granatum L), in addition to its ancient historical uses, has been used in several systems of medicine for a variety of ailments. 
Pomegranate juice is a polyphenol-rich juice with high antioxidant capacity pomegranate consumption possesses a diverse array of biological 
actions and may be helpful in the prevention of some inflammatory-mediated diseases including cancer. In the past decade, numerous studies 
on the antioxidant, anticarcinogenic, and anti-inflammatory properties of pomegranate constituents focusing on treatment and prevention of 
cancer, cardiovascular disease, diabetes, dental conditions. Currently, numerous clinical trials are in progress exploring the therapeutic potential of 
pomegranate extracts.
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INTRODUCTION
Name of the Medicinal Plant: Punica granatum L.
Family: Punicaceae
Common name: Pomegranate [1]
Pomegranate (P. granatum L.) is considered one of the oldest known 
edible fruits and is symbolic of abundance and prosperity. For thousands 
of years, many cultures have believed that pomegranate has beneficiary 
effects on health, fertility, longevity, and rebirth [2].
The pomegranate tree typically grows 12-16 ft, has many spiny 
branches and can be extremely long-lived, as evidenced by trees at 
Versailles, France, known to be over 200 years old. The leaves are glossy 
and lance-shaped, and the bark of the tree turns gray as the tree ages. 
The flowers are large, red, white, or variegated and have a tubular calyx 
that eventually becomes the fruit. The ripe pomegranate fruit can be 
up to 5″ wide with a deep red, leathery skin, is grenade-shaped, and 
crowned by the pointed calyx. The fruit contains many seeds (arils) 
separated by white, membranous pericarp, and each is surrounded 
by small amounts of tart, red juice. The pomegranate is native from 
the Himalayas in northern India to Iran but has been cultivated and 
naturalized since ancient times over the entire Mediterranean region. It 
is also found in India and more arid regions of Southeast Asia, the East 
Indies, and tropical Africa. The tree is also cultivated for its fruit in the 
drier regions of California and Arizona [3].
In addition to, its ancient historical uses, pomegranate is used in 
several systems of medicine for a variety of ailments. In Ayurvedic 
medicine, the pomegranate is considered “a pharmacy unto 
itself” and is used as an antiparasitic agent, a “blood tonic,” and to 
heal aphthae, diarrhea, and ulcers. Pomegranate also serves as a 
remedy for diabetes in the Unani system of medicine practiced in 
the Middle East and India. The potential therapeutic properties of 
pomegranate are wide ranging and include treatment and prevention 
of cancer, cardiovascular disease, diabetes, dental conditions, 
erectile dysfunction, and protection from ultraviolet radiation. Other 
potential applications include infant brain ischemia, Alzheimer’s 
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MEDICAL IMPLICATIONS
Antioxidant mechanisms
An in vitro assay using four separate testing methods demonstrated 
pomegranate juice (PJ) and seed extracts have 2-3 times the antioxidant 
capacity of either red wine or green tea [4]. Pomegranate extracts 
have been shown to scavenge free radicals and decrease macrophage 
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oxidative stress and lipid peroxidation in animals and increase plasma 
antioxidant capacity in elderly humans [5].
Research in humans has shown a juice made from pomegranate 
pulp (PPJ) has the superior antioxidant capacity to apple juice. 
Using the FRAP assay (ferric reducing/antioxidant power), Guo et al. 
found 250 mL PPJ daily for 4 weeks given to healthy elderly subjects 
increased plasma antioxidant capacity from 1.33 to 1.46 mmol while 
subjects consuming apple juice experienced no significant increase in 
antioxidant capacity. In addition, subjects consuming the PPJ exhibited 
significantly decreased plasma carbonyl content (a biomarker for 
oxidant/antioxidant barrier impairment in various inflammatory 
diseases) compared to subjects taking apple juice. Plasma Vitamin E, 
ascorbic acid, and reduced glutathione values did not differ significantly 
between groups, leading researchers to conclude pomegranate 
phenolics may be responsible for the observed results [5].
Anticarcinogenic mechanism
In vitro assays utilizing three prostate cancer cell lines (DU-145, 
LNCaP, and PC-3) demonstrated various pomegranate extracts (juice, 
seed oil, peel) potently inhibit prostate cancer cell invasiveness 
and proliferation, cause cell cycle disruption, induce apoptosis, and 
inhibit tumor growth. These studies also demonstrated combinations 
of pomegranate extracts from different parts of the fruit were more 
effective than any single extract [1].
In an open-label, phase II clinical trial in 46 men with recurrent prostate 
cancer, 16 patients (35%) showed a significant decrease in serum 
prostate-specific antigen (PSA) levels (average=27%) during treatment 
with eight ounces of PJ. Corresponding in vitro assays using patient 
plasma and serum demonstrated significant decreases in prostate 
cancer cell line proliferation and increased apoptosis. Nitric oxide 
preservation via ingestion of pomegranate polyphenols significantly 
correlated with lower PSA values. These results indicate pomegranate 
may affect prostate cancer because of antiproliferative, apoptotic, 
antioxidant, and possibly anti-inflammatory effects [6]. Recent research 
also indicates pomegranate constituents inhibit angiogenesis via down-
regulation of vascular endothelial growth factor in MCF-7 breast cancer 
and human umbilical vein endothelial cell lines [1].
Anti-inflammatory mechanisms
Cold pressed pomegranate seed oil (CPSO) had been shown to 
inhibit both cyclooxygenase and lipoxygenase enzymes in vitro. 
Cyclooxygenase, a key enzyme in the conversion of arachidonic 
acid to prostaglandins (important inflammatory mediators), was 
inhibited by 37% by a CPSO extract. Lipoxygenase, which catalyzes 
the conversion of arachidonic acid to leukotrienes also key mediators 
of inflammation, was inhibited by 75% by the CPSO extract. By 
comparison, a fermented PJ extract resulted in a 23.8% inhibition of 
lipoxygenase in vitro [1].
Another in vitro study that may have far-reaching implications for 
those suffering from osteoarthritis (OA) demonstrated pomegranate 
fruit extract (PFE) has a significant and broad inhibitory effect on 
matrix metalloproteinases (MMPs), a subgroup of collagenase enzymes 
expressed in high levels in arthritic joints and involved in the turnover, 
degradation, and catabolism of extracellular joint matrix. In pretreated 
human femoral OA chondrocytes, PFE inhibited interleukin-1β (IL-1β)-
induced destruction of proteoglycan, expression of MMPs at the cellular 
level, and phosphorylation and activation of mitogen-activated protein 
kinases (signal transduction molecules involved in MMP expression). 
The suppression of MMP expression in OA chondrocyte cultures by PFE 
suggests pomegranate constituents prevent collagen degradation and 
may inhibit joint destruction in OA patients [7].
HYPERTENSION
A small clinical trial demonstrated PJ inhibits serum angiotensin 
converting enzyme (ACE) and reduces systolic blood pressure in 
hypertensive patients. 10 hypertensive subjects (ages 62-77; seven men 
and three women) were given 50 mL/day PJ containing 1.5 mmol total 
polyphenols for 2 weeks. Two of seven patients were also diabetic and 
two were hyperlipidemic. 7 of 10 subjects (70%) experienced a 36% 
average decrease in serum ACE activity and a small, but significant, 5% 
decrease in systolic blood pressure [8].
MYOCARDIAL PERFUSION
In a double-blind, randomized, placebo-controlled trial, 39 patients 
were given either 240 mL PJ (polyphenol content not specified) (n=23) 
or a sports beverage of similar color, flavor, and caloric content daily 
for 3 months (n=16). Although both control and treatment patients 
demonstrated similar levels of stress-induced ischemia at baseline, 
at 3 months stress-induced ischemia increased in the placebo group 
(from 5.9±4.3 to 7.1±5.5) but decreased in the treatment group (from 
4.5±3.1 to 3.7±3.7). In addition, angina episodes increased 38% in the 
placebo group but decreased 50% in the treatment group (a net change 
of 88%). These results demonstrate a reduction in myocardial ischemia 
and improved myocardial perfusion (as measured by stress-induced 
ischemia) in patients consuming PJ [9].
DIABETES
In an animal model of diabetes, Huang et al. demonstrated the favorable 
effect of Pomegranate flower extract (PFLE) on lipid profiles and cardiac 
fibrosis of Zucker fatty diabetic rats. Rosenblat et al. investigated the 
effect of 50 mL/day PJ for 3 months on oxidative stress, blood sugar, 
and lipid profiles in 10 type 2 diabetic patients (history of diabetes for 
4-10 years) and 10 healthy controls (ages 35-71) [10].
In diabetic patients, triglyceride levels were 2.8 times greater; high-
density lipoprotein (HDL) cholesterol was 28% lower, and hemoglobin 
A1C (HbA1c) values were 59% higher than in control patients. Insulin 
was only slightly lower in patients than controls, and C-peptide 
(a proinsulin metabolite marker for endogenously secreted insulin) 
was slightly higher in diabetic patients than in healthy controls at 
baseline (indicating slight hyperinsulinemia). Consuming PJ for 
3 months did not significantly affect triglyceride, HDL cholesterol, 
HbA1C, glucose, or insulin values, but did lower serum C-peptide 
values by 23% compared to baseline in diabetic patients – a sign of 
improved insulin sensitivity.
PJ consumption also significantly reduced oxidative stress in the 
diabetic patients as evidenced by a 56% reduction in lipid peroxides 
and a 28% reduction in thiobarbituric reactive substances compared to 
baseline serum levels. In addition, a 39% decrease in uptake of oxidized 
low-density lipoprotein by human monocyte-derived macrophages 
(an early development in foam cell formation and atherogenesis) 
was observed in diabetic patients after PJ consumption. Researchers 
concluded that despite the sugars naturally present in PJ, consumption 
did not adversely affect diabetic parameters but had a significant effect 
on atherogenesis via reduced oxidative stress [10].
ALZHEIMER’S DISEASE
The neuroprotective properties of pomegranate polyphenols were 
evaluated in an animal model of Alzheimer’s disease. Transgenic 
mice with Alzheimer’s - like pathology treated with PJ had 50% less 
accumulation of soluble amyloid-beta and less hippocampal amyloid 
deposition than mice consuming sugar water, suggesting PJ may be 
neuroprotective. Animals also exhibited improved learning of water 
maze tasks and swam faster than control animals [1].
OBESITY
PFLE (400 or 800 mg/kg/day) given to obese hyperlipidemic mice for 
5 weeks caused significant decreases in body weight, the percentage of 
adipose pad weights, energy intake, and serum cholesterol, triglyceride, 
glucose, and total cholesterol/HDL ratios. Decreased appetite and 
intestinal fat absorption were also observed, improvements mediated 
in part by inhibition of pancreatic lipase activity [1].
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BACTERIAL INFECTIONS
The only human trials examining the antibacterial properties of 
pomegranate extracts have focused on oral bacteria. However, several 
in vitro assays demonstrate its bactericidal activity against several 
highly pathogenic and sometimes antibiotic-resistant organisms. 
Brazilian researchers evaluated the synergistic effect of a P. granatum 
methanolic extract with five antibiotics on 30 clinical isolates of 
methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-
sensitive S. aureus. 75 Antibiotics tested were chloramphenicol, 
gentamicin, ampicillin, tetracycline, and oxacillin. Although synergistic 
activity between the pomegranate extract and all five antibiotics was 
noted in the S. aureus isolates, synergy with ampicillin was the most 
pronounced. A combination of the two increased the lag time to 
bacterial growth by 3 hrs (over that of ampicillin alone) and was also 
bactericidal as evidenced by a 72.5% reduction in methicillin-sensitive 
organisms and a 99.9% reduction in MRSA. Based on earlier research 
76 and the results of this study, the ellagitannin, punicalagin, is thought 
to be the primary constituent responsible for the observed antibacterial 
effects. Another organism that can cause significant disease in humans 
is entero-hemorrhagic Escherichia coli (E. coli O157:H7), which can 
present with diarrhea, hemorrhagic colitis, thrombocytopenic purpura, 
and hemolytic uremic syndrome. P. granatum and seven other Thai 
medicinal plant extracts were tested for in vitro activity against E. coli 
O157:H7. An ethanolic PPE, one of the two most effective extracts 
against E. coli O157:H7, was shown to be both bacteriostatic and 
bactericidal, indicating PPE may be an effective adjunct treatment for 
E. coli O157:H7 infection [11].
DENTAL IMPLICATIONS
Topical applications of pomegranate preparations have been found 
to be particularly effective for controlling oral inflammation, as well 
as bacterial and fungal counts in periodontal disease and Candida-
associated denture stomatitis [1].
DENTAL PLAQUE
A hydroalcoholic extract of P. granatum fruit (HAEP) was investigated 
for antibacterial effect on dental plaque microorganisms. 60 healthy 
patients (33 females/27 males; ages 9-25) with fixed orthodontic 
appliances were randomized to three groups of 20: (1) Control group 
who rinsed with 15 mL distilled water; (2) a group who rinsed with 
15 mL chlorhexidine, a standard antiplaque mouth rinse; and (3) a 
group who rinsed with a 15 mL HAEP solution. Rinsing duration was 
1 minute, and dental plaque material was collected from each patient 
before and after rinsing. Samples were diluted and plated on Mueller-
Hinton agar and incubated at 37°C for 48 hrs. HAEP decreased the 
number of colonies forming units of dental plaque bacteria 84%, 
comparable to chlorhexidine (79% inhibition) but significantly better 
than the control rinse (11% inhibition). Both HAEP and chlorhexidine 
were effective against Staphylococcus, Streptococcus, Klebsiella, and 
Proteus species as well as E. coli. The ellagitannin, punicalagin, is 
thought to be the fraction responsible for pomegranate’s antibacterial 
activity [12].
CLINICAL STUDIES ON GINGIVITIS
Gingivitis is an inflammation of the gums in response to bacterial plaque 
biofilms adhering to tooth surfaces. If left untreated, gingivitis may 
progress to periodontal disease and subsequent tooth loss. There is an 
incentive to use alternative plant-based preparations as an adjunctive 
to mechanical therapy in the prevention and treatment of gingivitis, 
due to the health risks imposed by the long-term use of chemical and 
pharmaceutical preparations and the lack of available dental care in 
lesser-developed countries. Results of a randomized, clinical study of 
40 patients with chronic gingivitis showed that significant improvements 
were obtained in the group that used a pomegranate extract gel along 
with mechanical debridement for 7 days when compared with patients 
using only control gel or mechanical debridement for the 7-day test 
period [13]. Another placebo-controlled human clinical trial of 32 
young adults examined salivary measures relevant to oral health and 
gingivitis after using a pomegranate extract mouth rinse three times 
per day for 4 weeks or a placebo rinse [14]. Compared to the control 
group, those participants using the pomegranate rinse had reduced 
total protein associated with the presence of plaque forming bacteria, 
reduced activities related to cell injury, reduced levels of the sucrose-
degrading enzyme alpha-glucosidase, and increased activity of the 
enzyme ceruloplasmin, which protects against oral oxidative stress. 
Based on these results, the authors suggest the possibility of using 
pomegranate extracts in oral health products such as toothpaste and 
mouthwashes [15].
PERIODONTAL DISEASE
A preliminary and follow-up study by a group of Thai researchers 
investigated the effect of biodegradable chips impregnated with 
Centella asiatica and P. granatum pericarp on periodontal disease in 
20 patients with gum pocket depths of 5-8 mm. A baseline exam was 
performed and followed by root planning and scaling of target teeth. 
Subgingival placement of the medicated chips (treatment group) and 
non-medicated chips (placebo/control group) followed, and pocket 
depth, attachment level, bleeding, and gingival and plaque indexes 
were measured at baseline and after three and 6 months. All treatment 
sites demonstrated a trend toward decreasing plaque and significant 
improvements were noted in pocket depth and attachment level at 
3 months compared to placebo [16].
In the follow-up study, 15 patients who had completed standard 
periodontal therapy but still had pocket depths of 5-8 mm were 
implanted with the same medicated chips. The same parameters 
were measured again at baseline and after three and 6 months, but 
researchers also measured inflammatory markers IL-1β and IL-6. 
Significant improvement was noted in all re-measured parameters 
and confirmed by significant decreases in IL-1β and IL-6 at three and 
6 months compared to baseline [17].
DENTURE STOMATITIS
The primary etiologic factors for denture stomatitis are poor oral 
hygiene, inflammation from ill-fitting dentures, and Candida infection 
which manifest as swelling, pain, burning in the mouth, and aphthous 
ulcers. In a randomized, double-blind study of 60 subjects (ages 19-62) 
with candidiasis confirmed via mycological examination, the effect 
of a gel-based P. granatum bark extract (GPBE) was evaluated for its 
effect on healing of oral lesions and direct fungicidal effect. Patients 
were randomized into two groups of 30: One received miconazole oral 
gel ( standard therapy) and the other used GPBE, both three times 
daily for 15 days. Gels were applied to oral surfaces; dentures were 
removed and cleaned nightly and then brushed with the corresponding 
oral gels. All subjects reported an improvement in symptoms and 
general oral health. Clinical symptoms of those using miconazole were 
slightly better (27/30 satisfactory improvement) compared to GPBE 
(21/30 satisfactory improvement). Clearing of Candida infection was 
approximately the same in both groups (25/30 in the miconazole group 
and 23/30 in the GPBE group) [18].
Interestingly, despite randomized subject placement, there were three 
times more subjects with good oral hygiene scores in the miconazole 
group compared to the GPBE group, possibly accounting for the 
superior results observed by miconazole therapy. Furthermore, because 
the initial step in the development of Candida denture stomatitis is 
adherence of organisms to dentures and the miconazole gel was stickier 
than GPBE, contact duration of miconazole was longer. A stickier GPBE 
might result in improved clinical response [18].
SAFETY
No adverse effects have been reported on consuming pomegranate and 
its constituents, since time immemorial. In addition, animal studies 
have failed to report any toxicities at doses conventionally used in the 
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conventional system of medicine. Even the histopathological analyzes 
of pomegranate extract punicalagin were devoid of any toxic findings. 
Human trials using doses of PFEs up to 1420 mg/day (870 mg gallic 
acid equivalents), for 28 days, did not report any adverse changes in 
blood or urine laboratory values. Another study in 10 patients with 
carotid artery stenosis demonstrated that PJ consumption (121 mg/L 
EA equivalents) for up to 3 years had no toxic effect on the blood 
chemistry analysis for kidney, liver, and heart function [3].
CONCLUSION
An explosion of interest in the numerous therapeutic properties of 
P. granatum over the last decade has led to numerous in vitro, animal, 
and clinical trials. Pomegranate is a potent antioxidant, superior to red 
wine, and equal to or better than green tea. In addition, anticarcinogenic 
and anti-inflammatory properties suggest its possible use as a therapy 
or adjunct for prevention and treatment of several types of cancer 
and cardiovascular disease. Because of pomegranate’s antimicrobial 
properties, it may aid in preventing infection by dental pathogens, 
pathogenic E. coli O157:H7, and antibiotic-resistant organisms.
Pomegranate’s effect on bacterial pathogens has only been tested 
in vitro, however, necessitating human trials to refute or substantiate 
any clinical effect. The possibility that pomegranate extracts may also 
have an effect on several other disease processes, such as Alzheimer’s 
disease, OA, neonatal brain injury, male infertility, and obesity, 
underscores the need for more clinical research. Currently, numerous 
clinical trials are in progress exploring the therapeutic potential of 
pomegranate extracts. 
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